GHK-Cu is not approved for human or veterinary use by the FDA or any other regulatory body
Caro C, Pourmadadi M, Eshaghi MM, Rahmani E, Shojaei S, Paiva-Santos AC, Rahdar A, Behzadmehr R, Garca-Martn ML, Dez-Pascual AM
Not intended for human consumption, medical, veterinary, or household use
Glutathione is also involved in the synthesis of GSLs which upon hydrolysis to ITCs release sulfate 3,47
The copper center's accessibility to redox cycling enables GHK-Cu to modulate oxidative stress responses in tissues experiencing inflammation or ischemic conditions
As per the WHOs Director, by 18th March 2020, the ten countries that took part in the clinical trial are Thailand, Switzerland, Spain, South Africa, Norway, Iran, France, Canada, Bahrain, And Argentina